双氢青蒿素对下咽癌Fadu细胞凋亡的影响

贾立峰; 李晓明; 申宇鹏; 路秀英

doi:10.13201/j.issn.1001-1781.2016.21.005

双氢青蒿素对下咽癌Fadu细胞凋亡的影响

- 白求恩国际和平医院耳鼻咽喉头颈外科(石家庄, 050082)
基金项目:
河北省应用基础研究计划重点基础研究项目

详细信息

通讯作者: 李晓明,E-mail:xmlmo@126.com

中图分类号: R739.6

收稿日期: 2016-01-12

Effects of dihydroartemisinin on the apoptosis of Fadu cells

- Department of Otolaryngology Head and Neck Surgery, Bethune International Peace Hospital, Shijiazhuang, 050082, China

More Information

Corresponding author: LI Xiaoming, E-mail: xmlmo@126.com

Received Date: 12 January 2016

摘要

摘要: 目的:探讨双氢青蒿素(DHA)对下咽癌Fadu细胞凋亡的影响。方法:用不同浓度DHA干预下咽癌Fadu细胞,观察DHA对细胞形态的影响;分别于24 h或48 h后用MTT法检测细胞增殖的变化并计算IC₅₀值。用AnnexinⅤ-FITC凋亡检测试剂盒分析DHA对Fadu细胞凋亡的影响。用Western Blot法测定DHA对Bcl-2、Bcl-xl、Mcl-1、Bax和C-PARP凋亡相关基因的影响。结果:一定浓度的DHA可显著改变细胞的形态学变化,抑制下咽癌Fadu细胞增殖且明显增加凋亡细胞的数量,该变化与干预浓度和时间呈依赖关系。进一步研究结果提示,DHA可显著抑制Bcl-2、Bcl-xl和Mcl-1抗凋亡蛋白的表达,同时增加促凋亡蛋白Bax和C-PARP的表达。结论:DHA可显著抑制下咽鳞状细胞癌Fadu细胞的增殖,并明显增加细胞的凋亡,其机制与DHA调控Bcl-2家族密切相关。提示,Bcl-2家族成员在DHA抑制下咽鳞状细胞癌Fadu细胞增殖的过程中发挥了重要作用。
- 双氢青蒿素 /
- 下咽肿瘤 /
- 凋亡 /
- Bcl-2
Abstract: Objective: To investigate the effect of dihydroartemisinin (DHA) on the apoptosis of Fadu cells.Method: Fadu cells were treated with DMSO or different doses of DHA for 24 or 48 h.After that, IC50 values of DHA were calculated based on the cell viability tested via MTT assay, the cell morphology was observed,the percentage of apoptotic cells was analyzed with the Annexin V-FITC Apoptosis Detection Kit, and some important regulators of apoptosis,such as Bcl-2, Bcl-xl, Mcl-1, Bax, and C-PARP were determined by Western blotting.Result: Certain doses of DHA significantly inhibited the proliferation and induced apoptosis of Fadu cells in a dose & time-dependent manners. DHA also downregulated the expression of antiapoptotic proteins (Bcl-2, Bcl-xl, and Mcl-1) and upregulated the expression of proapoptotic proteins(Bax and C-PARP).Conclusion: DHA remarkably inhibited proliferation and induction of apoptosis in Fadu cells via affecting proteins of Bcl-2 family. DHA may be a promising drug to treat hypopharyngeal carcinoma.
- dihydroartemisinin /
- hypopharyngeal neoplasms /
- apoptosis /
- Bcl-2

HTML全文

参考文献(18)

[1]	MI Y J, GENG G J, ZOU Z Z, et al. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells[J]. PLoS One, 2015,10:e0120426-e0120426.
[2]	LUCIBELLO M, ADANTI S, ANTELMI E, et al. Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells[J]. Oncotarget, 2015, 6:5275-5291.
[3]	ZHANG C Z, ZHANG H, YUN J, et al. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo[J]. Biochem Pharmacol, 2012, 83:1278-1289.
[4]	ZHAO X, ZHONG H, WANG R, et al. Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxa-mediated pathway requiring iron and endoperoxide moiety[J]. Oncotarget, 2015, 6:5582-5596.
[5]	JIA G, KONG R, MA Z B, et al. The activation of c-Jun NH(2)-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells[J]. J Exp Clin Cancer Res, 2014, 33:8-12.
[6]	ZHANG Z S, WANG J, SHEN Y B, et al. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy[J]. Oncol Lett, 2015,10:379-383.
[7]	ZHAO C, GAO W, CHEN T. Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine[J]. Apoptosis, 2014,19:668-681.
[8]	TAKES R P, STROJAN P, SILVER C E, et al. Current trends in initial management of hypopharyngeal cancer:the declining use of open surgery[J]. Head Neck, 2012,34:270-281.
[9]	LIGIER K, BELOT A, LAUNOY G, et al. Descriptive epidemiology of upper aerodigestive tract cancers in France:incidence over 1980-2005 and projection to 2010[J]. Oral Oncol, 2011,47:302-307.
[10]	PFISTER D G, ANG K K, BRIZEL D M, et al. National comprehensive cancer network clinical practice guidelines in oncology head and neck cancers[J]. J Natl Compr Canc Netw, 2011, 9:596-650.
[11]	黄振河, 张月飞, 蒋东辉, 等. 双氢青蒿素诱导鼻咽癌CNE-2细胞凋亡及其机制[J]. 临床耳鼻咽喉头颈外科杂志, 2013, 27(13):717-720.
[12]	GAO X, LUO Z, XIANG T, et al. Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells[J]. Tumori, 2011,97:771-780.
[13]	HANDRICK R, ONTIKATZE T, BAUER K D, et al. Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway[J]. Mol Cancer Ther, 2010, 9:2497-2510.
[14]	CHEN T, LI M, ZHANG R, et al. Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy[J]. J Cell Mol Med, 2009,13:1358-1370.
[15]	LU C X, NAN K J, NIE Y L, et al. Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways[J]. Mol Biol Rep, 2010, 37:3407-3412.
[16]	KANG M H, REYNOLDS C P. Bcl-2 inhibitors:targeting mitochondrial apoptotic pathways in cancer therapy[J]. Clin Cancer Res, 2009,15:1126-1132.
[17]	GAO N, BUDHRAJA A, CHENG S, et al. Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo[J]. Apoptosis, 2011,16:511-523.
[18]	ZHOU H J, WANG Z, LI A. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression[J]. Anticancer Drugs, 2008,19:247-255.